Skip to main content
HealthConfirmedMediumDeveloping
5.3

Merck grants generic licenses for investigational monthly HIV prevention pill

Merck has authorized generic manufacturers in Africa to produce the investigational HIV prevention drug islatravir ahead of final clinical trial completion. This strategy aims to diversify HIV prevention options and accelerate regional pharmaceutical manufacturing capacity.

Mail & Guardianabout 10 hours agoZA, KE, UGCredibility 39%View source

Score Breakdown

Mosaic Score5.3
Confidence0.9
Significance0.5
Source credibility0.4
Source

Related signals

8 found